Arcturus Therapeutics | SC 13G:超过5%持股股东披露文件-Nikko Asset Management Americas, Inc.(8.56%)
Arcturus Therapeutics | SC 13G:超过5%持股股东披露文件-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(8.56%),Nikko Asset Management Co., Ltd. (“NAM”)(8.56%)
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-董事 Slaoui Moncef
Arcturus Therapeutics | 3:首次持股声明-董事 Slaoui Moncef
Arcturus Therapeutics | 4:持股变动声明-董事 Marantz Jing L.
Arcturus Therapeutics | 4:持股变动声明-董事 HOLMES EDWARD W
Arcturus Therapeutics | 4:持股变动声明-董事 Markels John
Arcturus Therapeutics | 4:持股变动声明-董事 Marquet Magda
Arcturus Therapeutics | 4:持股变动声明-董事 BARLOW JAMES F
Arcturus Therapeutics | 4:持股变动声明-董事 FARRELL PETER C
Arcturus Therapeutics | 4:持股变动声明-高管 SASSINE ANDY
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(10.2%)
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | 4:持股变动声明-高管 Chivukula Pad
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.46%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Nikko Asset Management Americas, Inc.(4.94%)
Arcturus Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Sumitomo Mitsui Trust Holdings, Inc. (“SMTH”)(4.94%),Nikko Asset Management Co., Ltd. (“NAM”)(4.94%)
暂无数据
暂无数据